Archives

Category Archive for: ‘PBM economic benefits’

  • Sovaldi: A Poster Child for Predatory Pricing

    In a previous post, we discussed how patients with chronic Hepatitis C virus (HCV) infections will benefit from Sovaldi (sofosbuvir) – one of a new class of blockbuster HCV drugs. It was reported that 95% of patients were cured by this drug during a 12-week …

    Read More
  • Academic Witnesses Criticize PBM Compensation Disclosure Mandates

    As we noted in an earlier piece, the ERISA Advisory Council this year is studying the issue of whether pharmacy benefit managers (PBMs) should be required to make compensation and fee disclosures to employee health plan sponsors.  On June 19, 2014, the Advisory Council held …

    Read More
  • Are Employer Health Plans Leaving Money on the Table With Their Pharmacy Benefits?

    An analysis released in late March by Avalere Health, “Consumers Face More Hurdles to Accessing Drugs in Exchange Plans Compared to Employer Coverage,” caught our attention. The analysis “finds that consumers purchasing insurance through exchanges are twice as likely to face utilization management controls on …

    Read More
  • A Pill Worth 60 Times Its Weight in Gold?

    I read a story the other day about politicians in Washington complaining that a new $1,000 Hepatitis C pill is too expensive. Since these are the guys that helped run up an $18 trillion national debt, I guess you need to take it seriously when …

    Read More
  • It’s Official – PBM Tools Likely to Save Alabama Medicaid $ Millions

    Alabama officials have been taking a hard look at ways to reduce the state’s spending on Medicaid while providing higher quality care.  A new report from the Alabama Medicaid Pharmacy Study Commission points the way.  According to the report, if Alabama were to reform its …

    Read More
  • New and Improved

    We have often written about how pharmacy benefit management tools are brought to bear in order to avoid wasteful prescription drug spending.  Now, the Wall Street Journal has published a piece, “New Medicines Emerge, but Few Blockbusters,” detailing how payers have been successful in resisting …

    Read More
  • Formulary Wars

    A long time ago in a galaxy far, far away, health plans would cover pretty much any prescription medication at prices set by drug companies.  But, over time, pharmacy benefit managers (PBMs) emerged and helped payers rebel against the Pharmaceutical Empire.  Cue John Williams music. …

    Read More
  • The Wide Variation in Generic Drug Prices at Pharmacies Increases Health Care Costs

    Affordability is a key feature of generic medications. However, recent studies have found cause for concern in the wide variation of generic drug prices at different retailers. A 2013 article by Consumer Reports reveals that there may be up to a 448% difference between the …

    Read More
  • New Actuarial Report Confirms Medicare Savings from Preferred Pharmacy Networks

    Last month we reported on a new academic study of the benefits of pharmacy networks.  Now there is additional data on the cost-saving potential of these networks for prescription benefit plans.  The Pharmaceutical Care Management Association (PCMA) has released a new actuarial study by the …

    Read More
  • Express Scripts Details Clinical Basis of Formulary Creation

    As part of their efforts to reduce client prescription costs, pharmacy benefit managers (PBMs) create formularies – list of drugs that are covered by prescription benefit plans they manage.  PBM Express Scripts was recently in the news for announcing that its 2014 formulary would exclude …

    Read More
Page 1 of 41234»